Advertisement

Topics

Latest "Oswald Companies" News Stories

15:47 EDT 14th August 2018 | BioPortfolio

Here are the most relevant search results for "Oswald Companies" found in our extensive news archives from over 250 global news sources.

More Information about Oswald Companies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Oswald Companies for you to read. Along with our medical data and news we also list Oswald Companies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Oswald Companies Companies for you to search.

Showing "Oswald Companies" News Articles 1–25 of 2,300+

Tuesday 14th August 2018

Hairy Cell Leukemia Pipeline Review, H1 2018 [Report Updated: 17042018] Prices from USD $2000

Hairy Cell Leukemia Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hairy Cell Leukemia Pipeline Review, H1 2018, provides an overview of the Hairy Cell Leukemia Oncology pipeline landscape.Hairy cell leukemia is a rare, slowgrowing cancer of the blood in which bone marrow makes too many B cells lymphocytes, a type of white blood...


Peptic Ulcers Pipeline Review, H1 2018 [Report Updated: 12062018] Prices from USD $2000

Peptic Ulcers Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peptic Ulcers Pipeline Review, H1 2018, provides an overview of the Peptic Ulcers Gastrointestinal pipeline landscape.Peptic ulcers are open sores that develop on the inside lining of esophagus, stomach and the upper portion of small intestine. Symptoms include nausea ...

AIM Pharma appoints CMO as clinic nears for ROSgard™ kidney protection drug

August 14th 2018: A1M Pharma announces that the company has appointed Tobias Larsson Agervald as its new Chief Medical Officer (CMO). Tobias Larsson Agervald is an associated professor and specialist in internal medicine and nephrology with extensive experience in global research and development of pharmaceuticals in both early and later clinical stages. He will assume the position on Decembe...


The Inception Companies to Launch First Cannabis REIT Sponsored by an Industry-Leading Investment Firm, Filling Void in the Real Estate Capital Markets

Inception REIT Will Provide Real Estate Capital Solutions, and a Yield-Oriented, Asset-Based Investment Opportunity The Inception Companies (“Inception”), a private investment firm with significant operating and investing experience across the regulated U.S. cannabis industry, is pleased to announce the launch of

Noble Named One of Orlando Sentinel’s Top 100 Companies for Third Year in a Row

Noble, the Orlando-based developer of patient-centric advanced drug delivery system training devices, has once again received top honors as one of the Orlando Sentinel’s Top 100 Greatest Companies for 2018, a list that recognizes outstanding places to work in Central Florida. Noble was previously awarded this honor in 2017 and 2016, as well as in 2014. P...

Inland Private Capital Corporation Completes Sale of Medical Office Properties in Illinois and Massachusetts

Inland Private Capital Corporation (“IPC”) today announced the sale of four freestanding medical office properties located in Illinois and Massachusetts for a gross sale price of $45.7 million. IPC, through its subsidiary which serves as asset manager, facilitated the sale of the properties on behalf of the Medical Office Portfolio DST, one of its 1031...

Press Release: Juha Tuominen, Chief Medical Officer of Terveystalo, has been elected as the Managing Director of Hospital District of Helsinki and Uusimaa

According to the public announcement of HUS, the Hospital District of Helsinki and Uusimaa, Juha Tuominen (Professor, MD, Ph.D), Chief Medical Officer of Terveystalo, has been elected as the new Managing Director of HUS, starting from January 1, 2019. Tuominen is yet to resign from his current position and he continues as the Chief Medical Officer of Terveystalo for the time being. ...

Chronic Myelocytic Leukemia CML, Chronic Myeloid Leukemia Pipeline Review, H1 2018 [Report Updated: 29052018] Prices from USD $2000

Chronic Myelocytic Leukemia CML, Chronic Myeloid Leukemia Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia Pipeline Review, H1 2018, provides an overview of the Chronic Myelocytic Leukemia Oncology pipeline landscape.Chronic myeloid leukemia CML, also known as chronic myelogenous leukemia, is a type of ...

Hardman & Co Research: Oxford BioMedica (OXB): Risk-sharing in cystic fibrosis gene-therapy

Hardman & Co Research 14-Aug-2018 / 07:15 GMT/BST Hardman & Co: Risk-sharing in cystic fibrosis gene-therapy OXB is a specialist, advanced-therapy, lentivirus vector biopharma company. It offers vector manufacturing and development services and has a proprietary drug pipeline. In addition to LentiVector(R) service contracts, OXB receives royalties on commercial therapies developed by...

Traumatic Brain Injury Pipeline Review, H2 2018 [Report Updated: 10072018] Prices from USD $2000

Traumatic Brain Injury Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury Pipeline Review, H2 2018, provides an overview of the Traumatic Brain Injury Central Nervous System pipeline landscape.Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually r...

Nasal Polyps Pipeline Review, H1 2018 [Report Updated: 12062018] Prices from USD $2000

Nasal Polyps Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps Pipeline Review, H1 2018, provides an overview of the Nasal Polyps Ear Nose Throat Disorders pipeline landscape.Nasal polyps Nasal polyposis is an inflammatory condition develops in the nasal lining of nose. They are noncancerous growths. Signs and symptoms...

Monday 13th August 2018

Serine/Threonine Protein Kinase A Raf Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1 Pipeline Review, H2 2018 [Report Updated: 10072018] Prices from USD $3500

Serine/Threonine Protein Kinase A Raf Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1 Pipeline Review, H2 2018SummaryAccording to the recently published report 'SerineThreonine Protein Kinase A Raf Pipeline Review, H2 2018'; Serine/Threonine Protein Kinase A Raf Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1 pipeline Target constitutes close to 5 molecules. O...

13 Massachusetts Life Science Companies Show Gains and Losses

Massachusetts in general and Boston, specifically Cambridge, is one of the two largest centers in the U.S. for biotech startups and life science companies (the other being the San Francisco Bay Area). Here’s a look at 13 Massachusetts life science companies that are showing both gains and losses—...

Hillman Group Capital Trust Announces Cash Distribution On Trust Preferred Securities

CINCINNATI, Aug. 13, 2018 /PRNewswire/ -- The Hillman Companies, Inc. ("Hillman" or the "Company"), – Gregory Gluchowski, President and CEO, of The Hillman Companies, Inc., Read more...

John Williams Joins Hawkins Point Partners as Chief Strategy Officer

Hawkins Point Partners added the role of Chief Strategy Officer to their leadership team and welcomed John Williams to take on that mantle. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180813005628/en/ John Williams, Chief Strategy Officer for Hawkins Point Partners, a technology con

Hyperinsulinemia Pipeline Review, H1 2018 [Report Updated: 12062018] Prices from USD $2000

Hyperinsulinemia Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperinsulinemia Pipeline Review, H1 2018, provides an overview of the Hyperinsulinemia Metabolic Disorders pipeline landscape.Hyperinsulinemia is a condition in which there are excess levels of insulin circulating in the blood relative to the level of glucose. Insu...

Tetrahydrofuran THF Market by Application PTMEG, Solvents, Technology Reppe Process, Davy Process, Propylene Oxide Process, Butadiene Process, and Region Asia Pacific, North America, Europe, RoW Global Forecast to 2022 [Report Updated: 27032018] Prices f

The Tetrahydrofuran THF market is projected to grow at a CAGR of 6.9%, in terms of value between 2017 and 2022. The THF market is projected to grow from USD 2.95 billion in 2017 to USD 4.12 billion by 2022, at a CAGR of 6.9% from 2017 to 2022. The increasing demand for spandex fibers and polyurethane across the globe is driving the growth of the THF market. The hazardous impact of tetrahydrofuran ...

Renal Anemia| A Drug Pipeline Analysis Report 2018| Technavio

Technavio has announced their latest pipeline analysis report on the drug pipeline for renal anemia. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat renal

Anthem Blue Cross and Blue Shield Adds Sullivan County Community Hospital to Its Medicare Advantage Provider Network

Anthem and Sullivan County Community Hospital collaborate to give consumers more options for high-quality healthcare Anthem Blue Cross and Blue Shield in Indiana (Anthem) is committed to increasing consumer access to high-quality, affordable healthcare. As part of this commitment, Anthem and Sullivan County Community Hospital (SCCH) announced today tha...

Gene Therapy For Cystic Fibrosis| A Drug Pipeline Analysis Report 2018| Technavio

Technavio has announced their latest pipeline analysis report on the drug pipeline for gene therapy for cystic fibrosis. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat

Dermatomyositis | A Drug Pipeline Analysis Report 2018 | Technavio

Technavio has announced their latest analysis report on the drug pipeline for dermatomyositis. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat dermatomyositis. This press release features multimedia. View the full release here:

Choroidal Neovascularization | A Drug Pipeline Analysis Report 2018 | Technavio

Technavio has announced their latest pipeline analysis report on the drug pipeline for choroidal neovascularization. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat choroidal neovascularization. This pres

Prostate Specific Antigen Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77 Pipeline Review, H1 2018 [Report Updated: 12062018] Prices from USD $3500

Prostate Specific Antigen Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77 Pipeline Review, H1 2018SummaryAccording to the recently published report 'Prostate Specific Antigen Pipeline Review, H1 2018'; Prostate Specific Antigen Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77 pipeline Target constitutes close ...

Uterine Leiomyoma Uterine Fibroids Pipeline Review, H2 2018 [Report Updated: 24072018] Prices from USD $2000

Uterine Leiomyoma Uterine Fibroids Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uterine Leiomyoma Uterine Fibroids Pipeline Review, H2 2018, provides an overview of the Uterine Leiomyoma Uterine Fibroids Non Malignant Disorders pipeline landscape.Uterine fibroids are benign tumors that originate in the uterus womb. Although th...

Protein Kinase C Theta Type nPKC Theta or PRKCQ or EC 2.7.11.13 Pipeline Review, H1 2018 [Report Updated: 22052018] Prices from USD $3500

Protein Kinase C Theta Type nPKC Theta or PRKCQ or EC 2.7.11.13 Pipeline Review, H1 2018SummaryAccording to the recently published report 'Protein Kinase C Theta Type Pipeline Review, H1 2018'; Protein Kinase C Theta Type nPKC Theta or PRKCQ or EC 2.7.11.13 pipeline Target constitutes close to 9 molecules. Out of which approximately 7 molecules are developed by companies and remaining by the uni...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks